LIS

Production Well Program Update

Retrieved on: 
Donnerstag, August 10, 2023
Lithium, Well, Agricultural Development in the American Pacific, Advertising, Communication, CAD, Editorial, Civil and Electrical Projects Contracting Company, Corporation, Project, LIS, Platinum, Corporate development

Phase Two will site an additional three production wells within a zone across the Norma Edit and Viamonte Claim blocks.

Key Points: 
  • Phase Two will site an additional three production wells within a zone across the Norma Edit and Viamonte Claim blocks.
  • The total program will range between 1,000 and 1,500 meters with a budgeted value of between US$1.2 million to US$1.8 million.
  • The program will utilize non-generic marketing channels to provide Company exposure to fresh investment audiences.
  • The advertising program is budgeted for US$350,000 over a nine-month term.

Production Well Program Update

Retrieved on: 
Donnerstag, August 10, 2023
Lithium, Well, Agricultural Development in the American Pacific, Advertising, Communication, CAD, Editorial, Civil and Electrical Projects Contracting Company, Corporation, Project, LIS, Platinum, Corporate development

Phase Two will site an additional three production wells within a zone across the Norma Edit and Viamonte Claim blocks.

Key Points: 
  • Phase Two will site an additional three production wells within a zone across the Norma Edit and Viamonte Claim blocks.
  • The total program will range between 1,000 and 1,500 meters with a budgeted value of between US$1.2 million to US$1.8 million.
  • The program will utilize non-generic marketing channels to provide Company exposure to fresh investment audiences.
  • The advertising program is budgeted for US$350,000 over a nine-month term.

U.S. FORECLOSURE ACTIVITY DIPS IN JULY 2023 WHILE LENDER REPOSSESSIONS CONTINUE TO CLIMB

Retrieved on: 
Donnerstag, August 10, 2023
Database, REO, Housing, NTS, REO Motor Car Company, File, NOD, NFS, Real estate owned, AL, LIS, Foreclosure, Commercial property, Real estate, Casino, Maid service, MD

IRVINE, Calif., Aug. 10, 2023 /PRNewswire/ -- ATTOM, a leading curator of land, property, and real estate data, today released its July 2023 U.S. Foreclosure Market Report, which shows there were a total of 31,877 U.S. properties with foreclosure filings — default notices, scheduled auctions or bank repossessions — down 9 percent from a month ago but up 5 percent from a year ago. 

Key Points: 
  • "The slight decline in foreclosure filings we are seeing is yet another sign of a rebounding housing market," said Rob Barber, CEO at ATTOM.
  • "With home prices back up, several factors have combined to put more financial resources in the hands of homeowners, providing more options to avoid foreclosure.
  • Nationwide one in every 4,380 housing units had a foreclosure filing in July 2023.
  • Lenders started the foreclosure process on 21,020 U.S. properties in July 2023, down 12 percent from last month and down 2 percent from a year ago.

EQS-News: SYNLAB AG: Continued strong performance in the second quarter of 2023

Retrieved on: 
Mittwoch, August 9, 2023
Omicron, FY, Stock dilution, COVID-19, Term loan, D2C, Prognosis, COVID-19 testing, EDT, Sale, EBITDA, FX, CEST, AOP, Growth, LIS, EPS, GBP, Beauty salon, Pharmaceutical industry, Cryptocurrency, AEBITDA, Synnovis

The second quarter saw revenues of €670 million (Q2 2022: €790 million) including only €7 million from COVID-19 testing (Q2 2022: €164 million).

Key Points: 
  • The second quarter saw revenues of €670 million (Q2 2022: €790 million) including only €7 million from COVID-19 testing (Q2 2022: €164 million).
  • Underlying organic growth (excluding COVID-19 testing revenue) accelerated in H1 2023 to 7.1% in comparison to H1 2022 (3.1% normalized for Synnovis).
  • Q2 2023 underlying growth was 4.4% with a volume growth of 3.5% and a price increase of 0.9%.
  • In line with its active portfolio management strategy that aims to improve Group performance, SYNLAB sold its operations in Switzerland in July 2023.

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Retrieved on: 
Dienstag, August 8, 2023
Reflex, Laboratory, Workflow, CML, EMR, BCR, Mutation, BCR-ABL, Cell, Electronic health record, Point mutation, Patient, Cell division, LIS, Diagnosis, Health, ABL1, Economics, Chronic myelogenous leukemia, Medical device, HAVEN

NEW HAVEN, Conn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces the launch of its new quantitative BCR-ABL 2.0 panel, with features making it the most innovative panel of its kind on the market.

Key Points: 
  • NEW HAVEN, Conn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces the launch of its new quantitative BCR-ABL 2.0 panel, with features making it the most innovative panel of its kind on the market.
  • For more information on this new panel please visit us at https://tinyurl.com/QBCR-ABL1 .
  • The following features make this product the most advanced BCR-ABL panel on the market, besting competition in terms of robust coverage, workflow ease, accuracy, and cost:
    1.
  • Precipio’s HemeScreen BCR-ABL 2.0 assay is the only panel on the market that provides quantitative coverage of four clinically relevant2,3 breakpoints – p.190, p.210, p.203 and p.230.

Thermo Fisher Scientific Launches Scalable Diomni Enterprise Software for Molecular Diagnostics Labs and Test Developers

Retrieved on: 
Donnerstag, Juli 13, 2023
Science, Software, Other Science, Biotechnology, Research, Health, Data Management, Technology, AACC, Workflow, Thermo Fisher Scientific, Real-time, Documentation, LIS, American Association for Clinical Chemistry, PCR, Medical device

To address challenges with error-prone, manual molecular testing workflows, Thermo Fisher Scientific today has introduced Diomni Enterprise Software, helping streamline routine diagnostics testing for standardization and faster time-to-results.

Key Points: 
  • To address challenges with error-prone, manual molecular testing workflows, Thermo Fisher Scientific today has introduced Diomni Enterprise Software, helping streamline routine diagnostics testing for standardization and faster time-to-results.
  • By connecting workflow steps within one interface, Diomni Enterprise can increase a lab’s ability to dynamically respond to today’s rapidly changing testing environment.
  • Molecular diagnostics clinical labs and kit manufacturers often suffer from antiquated systems that can be hard to scale for increased throughput or expanding test menu.
  • The Diomni Enterprise software will be available for live demonstrations in Thermo Fisher Scientific’s booth #2118 at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo from July 23-27, 2023 in Anaheim, Calif. To learn more about the Diomni Enterprise Software, please visit thermofisher.com/diomni.

University of Florida College of Medicine – Jacksonville Adopts Paige’s AI for Enhanced Cancer Diagnosis

Retrieved on: 
Dienstag, Juli 11, 2023
University, Biotechnology, Education, Technology, Health, General Health, Oncology, Health Technology, Other Technology, Software, Artificial Intelligence, University of Florida College of Medicine, Florida College, Medical laboratory, Marie Cassidy, Pathology, Prostate, Attention, Professor, Patient, LIS, Diagnosis, AI, Laboratory, Medical device, Medicine

Paige , a global leader in end-to-end digital pathology solutions and clinical artificial intelligence (AI) applications for diagnosing cancer, and University of Florida College of Medicine – Jacksonville today announced the Department of Pathology and Laboratory Medicine’s decision to adopt Paige’s full portfolio of AI offerings for their lab, including the Paige Prostate Suite and Paige Breast Suite.

Key Points: 
  • Paige , a global leader in end-to-end digital pathology solutions and clinical artificial intelligence (AI) applications for diagnosing cancer, and University of Florida College of Medicine – Jacksonville today announced the Department of Pathology and Laboratory Medicine’s decision to adopt Paige’s full portfolio of AI offerings for their lab, including the Paige Prostate Suite and Paige Breast Suite.
  • Paige’s clinic–ready AI applications will be introduced to pathologists for use as a diagnostic adjunct, helping them to manage growing demand for their services by offering greater diagnostic efficiency and accuracy across prostate and breast cancer cases.
  • “The choice to adopt AI was made, first and foremost, with our patients in mind,” said Dr. Shahla Masood, Professor and Chair, Department of Pathology and Laboratory Medicine, University of Florida College of Medicine – Jacksonville.
  • “We are committed to providing our patients with the best possible outcomes, and to improving the diagnostic experience for our pathologists.

Laboratory Information System (LIS) Market worth $4.0 billion | MarketsandMarkets

Retrieved on: 
Montag, Juli 10, 2023
CGM, Communication, Epic Systems, Evidence, Accreditation, Public, Safety, Labcorp, Health, Acquisition, Oracle Corporation, Toxicology, Medicus, Catholic Church, Comp, Health information management, LabVantage, Health care, Grand American, Data analysis, Computer program, Research, Electronic health record, Laboratory information management system, Laboratory, Patient safety, Quality control, LIS, LabWare, Workflow, University of Cambridge Computing Service, Data management, Cerner, Workload, PACS, Intelligence, GHG, GPI, Decision, Decision support system, Deen Dayal Mobile Health Clinic, Medical device, Nursing, Retail, Fine chemical

In May 2023, Clinisys acquired Promium, a provider of laboratory information management systems for environmental and analytical testing laboratories.

Key Points: 
  • In May 2023, Clinisys acquired Promium, a provider of laboratory information management systems for environmental and analytical testing laboratories.
  • Labcorp would manage hospital-based laboratories in 10 states using Cerner's laboratory information system (LIS), aiming to enhance patient care and improve lab efficiency.
  • In November 2022, CompuGroup Medical (CGM) announced two add-on acquisitions in the areas of data solutions and US laboratory information systems.
  • High-Throughput Screening Market - Report Highlights:
    Market Overview: This edition includes updated market dynamics and market ecosystems specific to the laboratory information systems market.

Laboratory Information System (LIS) Market worth $4.0 billion | MarketsandMarkets

Retrieved on: 
Montag, Juli 10, 2023
CGM, Communication, Epic Systems, Evidence, Accreditation, Public, Safety, Labcorp, Health, Acquisition, Oracle Corporation, Toxicology, Medicus, Catholic Church, Comp, Health information management, LabVantage, Health care, Grand American, Data analysis, Computer program, Research, Electronic health record, Laboratory information management system, Laboratory, Patient safety, Quality control, LIS, LabWare, Workflow, University of Cambridge Computing Service, Data management, Cerner, Workload, PACS, Intelligence, GHG, GPI, Decision, Decision support system, Deen Dayal Mobile Health Clinic, Medical device, Nursing, Retail, Fine chemical

In May 2023, Clinisys acquired Promium, a provider of laboratory information management systems for environmental and analytical testing laboratories.

Key Points: 
  • In May 2023, Clinisys acquired Promium, a provider of laboratory information management systems for environmental and analytical testing laboratories.
  • Labcorp would manage hospital-based laboratories in 10 states using Cerner's laboratory information system (LIS), aiming to enhance patient care and improve lab efficiency.
  • In November 2022, CompuGroup Medical (CGM) announced two add-on acquisitions in the areas of data solutions and US laboratory information systems.
  • High-Throughput Screening Market - Report Highlights:
    Market Overview: This edition includes updated market dynamics and market ecosystems specific to the laboratory information systems market.

Amended rules for transparency calculations to start applying on 5 June 2023

Retrieved on: 
Sonntag, Juni 11, 2023
SI, ETF, European Securities and Markets Authority, Register, XML, Markets in Financial Instruments Directive 2014, RTS 2, LIS, ESMA, RTS, Security (finance), Mail, Information technology, Medical device

Amended rules for transparency calculations to start applying on 5 June 2023

Key Points: 
  • Amended rules for transparency calculations to start applying on 5 June 2023
    The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, today informs stakeholders that the amended RTS 1 and RTS 2, under MiFIR, will start applying on 5 June 2023.
  • Some of the amendments will have an impact on the transparency calculations for equity, equity-like and non-equity instruments.
  • The Financial Instruments Transparency System (FITRS) system provides in the results only the pre-trade LIS value since different thresholds are possible on the post-trade side.
  • Due to IT constraints, the publication of the new applicable value can only be done on the application date.